Showing posts with label FEB 05 2018. Show all posts
Showing posts with label FEB 05 2018. Show all posts

Monday 5 February 2018

FEB 05 2018, NEW PATENTS

FEB 052018
12 new patents,

Sr no
Patent number
name
company
INDICATION
REMARKS, WAIT FOR STR TO APPEAR
1
WO-2018023009

LURASIDONE
CONCERT
Bipolar I disorder; Schizophrenia
Lurasidone.svg
2
WO-2018022704

SELEXIPAG
TEVA

Pulmonary artery hypertension

Selexipag.svg
3
WO-2018021818

FEBUXOSTAT
HANMI
Gout; Hyperuricemia; Tumor lysis syndrome
Image result for febuxostat






4
WO-2018021517

AMISELIMOD
MITSUBISHI
Autoimmune disease; Crohns disease; Inflammatory bowel disease; Multiple sclerosis; Psoriasis
Image result for AMISELIMOD
5

WO-2018020506

CANAGLIFLOZIN
NATCO
Non-insulin dependent diabetes
Canagliflozin structure.svg
6
WO-2018020450

ELUXADOLINE
LUPIN

Diarrhea predominant irritable bowel syndrome

Eluxadoline.svg
7
WO-2018020406

BELINOSTAT
FRASENIUS
CANCER
Belinostat.svg
8
WO-2018020380

DOLUTEGRAVIR
LUPIN
HIV infection
Dolutegravir.svg
9

WO-2018020366

TRANYLCYPROMINE
GSK
Depression; Parkinsons disease
Tranylcypromine.svg
10
WO-2018019549

OMACETAXINE
INDENA

Chronic myelocytic leukemia

Omacetaxine mepesuccinate.svg
11
WO-2018019196

IXAZOMIB
SHENZEN
CANCER
Ixazomib.svg
12

WO-2018018986

CERITINIB
ARROMAX
Cardiovascular disease; Infectious disease; Inflammatory disease; Metabolic disorder; Viral infection
Ceritinib structure.svg
13





14





15





16